American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Vaxart, Inc. (VXRT)

$0.50 -0.90% OTC: VXRT · 15-min delayed

SOUTH SAN FRANCISCO, California
Public · OTC: VXRT
Founded 2004

Visit website Follow

$237.3MRevenue · FY2025

$16.3MNet income

VXRTOTC

2004Founded

About Vaxart, Inc.

VAXART INC

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Founded: 2004
Type: Public · OTC: VXRT
Headquarters: SOUTH SAN FRANCISCO, California
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: VXRT OTC
SEC CIK: 72444
EIN: 591212264
SIC: 2836 Biological Products, (No Diagnostic Substances)

Embed this company’s badge

Show Vaxart, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/vaxart-inc/"><img src="https://americancompanies.com/badge/vaxart-inc.svg" alt="Vaxart, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow Vaxart, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $237.3M
Net income: $16.3M
Total assets: $186.1M
Operating margin: -231.0%
Net margin: -233.3%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

FY2020

FY2021

FY2022

FY2023

FY2024

Revenue Net income

FY 2024

Financial statements

Income statement

Revenue: $28.7M
Operating expenses: $95.0M
Operating income: -$66.3M
Income tax: $260.0K
Net income: -$66.9M
EPS (basic): $-0.33

Balance sheet

Total assets: $166.4M
Current assets: $68.3M
Total liabilities: $107.5M
Current liabilities: $90.9M
Shareholders’ equity: $58.9M

Cash flow

Operating cash flow: -$44.8M
Investing cash flow: -$21.3M
Financing cash flow: $56.6M
Net cash flow: -$9.5M

Statements via Polygon.io (SEC filings)

OTC: VXRT

$0.50 -0.90%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.30 $0.80

52-week range

Open: —
Day range: –
Prev close: —
Volume: —

Vaxart, Inc. (VXRT) Stock Price

Profitable — net income of $16.3M in FY2025.
Revenue grew 609% from FY2020 to FY2024.
Trading 38% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Vaxart, Inc..

Write a review

Newsroom

News about Vaxart, Inc.

Vaxart Enters Cooperation Agreement with Stockholder Group and Announces Board and Corporate Governance Enhancements GlobeNewswire Inc. · 2026-07-01 · positive Vaxart Publishes Presentation Urging Shareholders to Vote “FOR” ALL Six of the Company’s Highly Qualified Director Nominees on the WHITE Proxy Card TODAY GlobeNewswire Inc. · 2026-06-26 · positive 3 Stocks Under $5 With Strong Analyst Upside Potential Investing.com · 2026-02-24 · positive Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program Benzinga · 2025-11-05 · positive Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program Benzinga · 2025-11-05 · positive Vaxart to Showcase its Norovirus and COVID-19 Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2025 GlobeNewswire Inc. · 2025-10-08 · positive

News & sentiment via Polygon.io

FAQ

Vaxart, Inc.: frequently asked questions

Is Vaxart, Inc. an American company?

Vaxart, Inc. is a US-based company headquartered in South San Francisco, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Vaxart, Inc. headquartered?

Vaxart, Inc. is headquartered in South San Francisco, California, United States.

Is Vaxart, Inc. publicly traded?

Yes — Vaxart, Inc. is a publicly traded company. Its stock trades under the ticker symbol VXRT on the OTC.

What does Vaxart, Inc. do?

Vaxart, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

When was Vaxart, Inc. founded?

Vaxart, Inc. was founded in 2004.

Explore